Source: Annual Congress 2013 –Asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Chishimba, D. Denning, C. Moore, G. Holtappels, T. Dutré, C. Bachert (Manchester, United Kingdom; De Pintelaan 185, Belgium). IgE expression in severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA). Eur Respir J 2013; 42: Suppl. 57, 853

Member's Comments

No comment yet.

Related content which might interest you: Vitamin D deficiency in asthma patients with allergic bronchopulmonary aspergillosis (ABPA) Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013 Prevalence of possible severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA) in a UK secondary care hospital Source: Annual Congress 2013 –Epidemiology of asthma Year: 2013 Subcutaneous allergen specific immunotherapy and immunological response in patients with bronchial asthma and allergic rhinitis in India Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 IL-17A in severe asthma, severe asthma with fungal sensitisation and ABPA Source: International Congress 2015 – Phenotyping asthma with biomarkers Year: 2015 Bronchopulmonary aspergillosis Source: Respipedia Article Year: 2017 Skin prick test versus specific IgE – A comparative study in patients with bronchial asthma and allergic rhinitis in India Source: International Congress 2014 – Clinical allergy Year: 2014 Sputum eosinophilia in severe allergic asthma is not a reliable marker of omalizumab treatment Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015 Autoimmune disorders in allergen immunotherapy, allergic rhinitis, and non-allergic patients Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 Prevalence of allergic bronchopulmonary aspergillosis in patients with uncontrolled asthma: An experience from southwestern Iran Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015 Combined therapy of asthma and allergic rhinitis Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Asthma control with omalizumab treatment in severe allergic asthma and severe non-allergic asthma patients Source: International Congress 2015 – Asthma and lung immunology Year: 2015 Allergic rhinitis (AR), non allergic rhinitis (NAR) and doctor-diagnosed chronic lung diseases Source: International Congress 2014 – Lung function, COPD and inflammation Year: 2014 25(OH) vitamin D levels in pediatric asthma and allergic rhinitis Source: International Congress 2014 – More paediatric asthma Year: 2014 The allergy profile and accompanying sinonasal pathologies in patients with bronchial asthma Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015 Sensitization to moulds in patients with newly diagnosed allergic asthma Source: International Congress 2015 – Immune aspects of asthma and other airway diseases Year: 2015 The clinical and biological response to allergen-specific immunotherapy with basophil activation test (BAT) in the atopic diseases Source: International Congress 2015 – Immune aspects of asthma and other airway diseases Year: 2015 Omalizumab is equally effective in persistent allergic oral corticosteroid-dependent asthma whether due to seasonal allergens or to perennial allergens Source: International Congress 2015 – Asthma and lung immunology Year: 2015 Allergic bronchopulmonary aspergillosis and other fungal diseases Source: Eur Respir Mon 2011; 52: 97-114 Year: 2011 Allergen analysis of 2778 patients with allergic diseases in China Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 Frequency of bronchial asthma (BA) symptoms, allergic rhinitis and allergic dermatitis among pregnants of Saint-Petersburg Source: Annual Congress 2008 - Asthma epidemiology Year: 2008